Corporate Banner
Satellite Banner
Technology Networks Header
Monday, September 15, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Thermo Scientific Unveils LC-MS Software to Transform High Performance Mass Spectrometry
Tuesday, June 11, 2013
Company introduces 10 new or updated software packages at ASMS.

Thermo Scientific Introduces New-generation Triple Quadrupole LC-MS Platform
Tuesday, June 11, 2013
New Thermo Scientific TSQ Quantiva LC-MS breaks attogram sensitivity barrier.

Thermo Fisher Scientific Launches World’s First “Tribrid” LC-MS System
Tuesday, June 11, 2013
Transforming life sciences research with revolutionary depth of analysis and usability.

Bruker Announces Powerful New Mass Spectrometry Systems and Solutions
Tuesday, June 11, 2013
Company announces mass spectrometry-based product introductions for life-science research, clinical research, pharma and applied markets.

Bruker Unveils Mass Spectrometry-Based Products at ASMS
Monday, June 10, 2013
Bruker announces powerful new mass spectrometry systems and solutions for life-science research, clinical research, pharma and applied markets.

Metabolon Expands Biochemical Profiling Capabilities
Wednesday, April 24, 2013
New TrueVision™ offering combines Company’s powerful biochemical profiling discovery platform with complex lipid profiling.

Extended Mass Spec Imaging Services Now Available
Tuesday, April 16, 2013
Mass Spec Imaging Center offers MSI service.

EZ Access To Evaporator Information
Wednesday, January 09, 2013
Genevac has created a web microsite dedicated to providing visitors with easy access to comprehensive background information relating to its flagship EZ-2 Series of compact, benchtop personal evaporators.

Agilent and PREMIER Biosoft’s Platforms Work Together to Advance Lipidomics Research
Monday, October 29, 2012
Complementary tools eliminate bottlenecks in data processing and analysis.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 333
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv